Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor

Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor

US Patent 6482829 · Granted Nov 19, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CGAS inhibiting triazolopyrimidone derivatives2025
Isoindolinone and indazole compounds for the degradation of EGFR2025
EGFR inhibitors for the treatment of cancer2025
Inhibitors2025
Isoindolinone and indazole compounds for the degradation of EGFR2025
Dihydrobenzimidazolones for medical treatment2025
Benzodiazepine derivatives as GABA A gamma 1 PAM2025
EGFR inhibitor for the treatment of cancer2025
Spirocyclic compounds2025
Spirocyclic compounds2025
Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant canc2025
Dihydroquinolinones for medical treatment2024